Prevalence and risk factors for malignant nodal involvement in early esophago-gastric adenocarcinoma: results from the multicenter retrospective CONGRESS study (endoscopic resection, esophagectomy or gastrectomy for early esophagogastric cancers)
Prevalence and risk factors for malignant nodal involvement in early esophago-gastric adenocarcinoma: results from the multicenter retrospective CONGRESS study (endoscopic resection, esophagectomy or gastrectomy for early esophagogastric cancers)
Objective: the aim of this study was to quantify LNM risk and outcomes following treatment of early esophago-gastric (EG) adenocarcinoma.
Background: the standard of care for early T1N0 EG cancer is endoscopic resection (ER). Radical surgical resection is recommended for patients perceived to be at risk of lymph node metastasis (LNM). Current models to select organ-preserving vs. surgical treatment are inconsistent.
Methods: CONGRESS is a UK-based multicentre retrospective cohort study. Patients diagnosed with clinical or pathological T1N0 EG adenocarcinoma from 2015-2022 were included. Outcomes and rates of LNM were assessed. Cox regression was performed to assess the impact of prognostic and treatment factors on overall survival.
Results: : 1,601 patients from 26 centres were included, with median follow-up 32 months(IQR 14-53). 1285/1612(80.3%) underwent ER, 497/1601(31.0%) underwent surgery. Overall rate of LNM was 13.5%. On ER staging, tumour depth (T1bsm2-3 17.6% vs. T1a 7.1%), lymphovascular invasion (17.2% vs. 12.6%), or signet cells (28.6% vs. 13.0%) were associated with LNM. In multivariable regression analysis, these were not significantly associated with LNM rates or survival. Adjusting for demographic and tumour variables, surgery after ER was associated with significant survival benefit, HR 0.33(0.15-0.77),P=0.010.
Conclusion: this large multicentre dataset suggests that early EG adenocarcinoma is associated with significant risk of LNM. This data is representative of current real clinical practice with ER-based staging, and suggests previously held beliefs regarding reliability of predictive factors for LNM may need to be reconsidered. Further research to identify patients who may benefit from organ-preserving vs. surgical treatment is urgently required.
Pucher, Philip H.
88d1340c-f1df-448d-a816-84fdefca48a1
Rahman, Saqib A.
2151f699-9a54-4bfc-91fe-3b8160f7551a
Bhandari, Pradeep
9d37fe08-4c8f-4d82-b3aa-52ba48706e15
Underwood, Tim
8e81bf60-edd2-4b0e-8324-3068c95ea1c6
the CONGRESS collaborative
Pucher, Philip H.
88d1340c-f1df-448d-a816-84fdefca48a1
Rahman, Saqib A.
2151f699-9a54-4bfc-91fe-3b8160f7551a
Bhandari, Pradeep
9d37fe08-4c8f-4d82-b3aa-52ba48706e15
Underwood, Tim
8e81bf60-edd2-4b0e-8324-3068c95ea1c6
Pucher, Philip H., Rahman, Saqib A. and Bhandari, Pradeep
,
et al. and the CONGRESS collaborative
(2024)
Prevalence and risk factors for malignant nodal involvement in early esophago-gastric adenocarcinoma: results from the multicenter retrospective CONGRESS study (endoscopic resection, esophagectomy or gastrectomy for early esophagogastric cancers).
Annals of Surgery, [10.1097/SLA.0000000000006496].
(doi:10.1097/SLA.0000000000006496).
Abstract
Objective: the aim of this study was to quantify LNM risk and outcomes following treatment of early esophago-gastric (EG) adenocarcinoma.
Background: the standard of care for early T1N0 EG cancer is endoscopic resection (ER). Radical surgical resection is recommended for patients perceived to be at risk of lymph node metastasis (LNM). Current models to select organ-preserving vs. surgical treatment are inconsistent.
Methods: CONGRESS is a UK-based multicentre retrospective cohort study. Patients diagnosed with clinical or pathological T1N0 EG adenocarcinoma from 2015-2022 were included. Outcomes and rates of LNM were assessed. Cox regression was performed to assess the impact of prognostic and treatment factors on overall survival.
Results: : 1,601 patients from 26 centres were included, with median follow-up 32 months(IQR 14-53). 1285/1612(80.3%) underwent ER, 497/1601(31.0%) underwent surgery. Overall rate of LNM was 13.5%. On ER staging, tumour depth (T1bsm2-3 17.6% vs. T1a 7.1%), lymphovascular invasion (17.2% vs. 12.6%), or signet cells (28.6% vs. 13.0%) were associated with LNM. In multivariable regression analysis, these were not significantly associated with LNM rates or survival. Adjusting for demographic and tumour variables, surgery after ER was associated with significant survival benefit, HR 0.33(0.15-0.77),P=0.010.
Conclusion: this large multicentre dataset suggests that early EG adenocarcinoma is associated with significant risk of LNM. This data is representative of current real clinical practice with ER-based staging, and suggests previously held beliefs regarding reliability of predictive factors for LNM may need to be reconsidered. Further research to identify patients who may benefit from organ-preserving vs. surgical treatment is urgently required.
Text
prevalence_and_risk_factors_for_malignant_nodal.1053
- Accepted Manuscript
More information
e-pub ahead of print date: 2 September 2024
Additional Information:
e-prints please check embargo conditions
Identifiers
Local EPrints ID: 495488
URI: http://eprints.soton.ac.uk/id/eprint/495488
ISSN: 0003-4932
PURE UUID: 9cf8b8ea-fafa-4706-a8f5-63826cdfbeae
Catalogue record
Date deposited: 14 Nov 2024 17:59
Last modified: 19 Nov 2024 02:38
Export record
Altmetrics
Contributors
Author:
Philip H. Pucher
Author:
Saqib A. Rahman
Author:
Pradeep Bhandari
Corporate Author: et al.
Corporate Author: the CONGRESS collaborative
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
